Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000885376 | SCV001028816 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004028348 | SCV002640059 | likely benign | not specified | 2022-02-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000885376 | SCV004125799 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | OBSCN: BP4, BP7, BS1, BS2 |
Prevention |
RCV003920638 | SCV004734311 | benign | OBSCN-related disorder | 2019-03-07 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |